A 74-year-old woman with prior Roux-en-Y gastric bypass (RYGB) presented to an outside facility with jaundice, anorexia, and weight loss. Her serum total bilirubin was 13 mg/dL; abdominal CT showed a pancreatic head mass. She was referred for EUS/ERCP to decompress the biliary system and provide a diagnosis.
After discussing the alternatives, we performed EUSguided hepaticogastrostomy (HG) (Video 1, available online at www.VideoGIE.org). EUS from the gastric pouch showed dilated left intrahepatic bile ducts up to 10 mm in diameter. The left hepatic duct was punctured transgastrically from the pouch under EUS guidance with a 19G needle, followed by cholangiography showing a 20-mm distal common bile duct (CBD) stricture (Fig. 1A) . A guidewire was passed antegrade into the duodenum. The HG was created by balloon dilation of the tract with a 4-mm balloon, followed by deployment of an 8-mm Â 10-cm long fully covered metal biliary stent from the left intrahepatic ducts to the gastric pouch under endoscopic and fluoroscopic guidance (Fig. 1B) . The CBD stricture was sampled by brush cytology in an antegrade fashion (Fig. 1C) . The procedure was completed with the patient as an outpatient, and there were no adverse events.
Postdrainage and preoperative triple-phase CT scanning showed a well-positioned HG stent and a resectable pancreatic head mass (Fig. 1D) . Brush cytology at the time of HG was interpreted as suggestive of malignancy. Serum bilirubin decreased to 1.3 mg/dL by 4 weeks, followed by a Whipple procedure and removal of the excluded stomach. Surgical pathologic examination confirmed pancreatic adenocarcinoma. Ten weeks postoperatively, the HG stent was electively removed from the gastric pouch endoscopically; antegrade cholangiography through the HG confirmed a patent choledochojejunostomy (Figs. 1E  and F) . The patient remains clinically well.
This case shows that preoperative, single-session EUSguided HG allows antegrade cholangiography with brush cytology to assess distal bile duct obstruction in patients with RYGB. This may be the only endoscopic approach for tissue acquisition from the CBD or head of pancreas in RYGB patients that preserves the integrity of the Roux-en-Y bypass in patients who are reluctant to reverse the bypass with a gastro-gastric fistula, and it can be considered as an alternative to laparoscopicassisted ERCP, ERCP performed through gastrostomy tracks, and percutaneous drainage. Moreover, EUSguided HG does not preclude or interfere with subsequent Whipple operation.
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